Cadila Healthcare has informed that it enclosed disclosure in prescribed Form C under Regulation 7[2] of SEBI [Prohibition of Insider Trading] Regulations, 2015, received from Nitin Parekh, Chief Financial Officer of the Company with respect to sale of 10,000 Equity Shares of Re 1 each in the open market.
The above information is a part of company’s filings submitted to BSE.